Cargando…

Objective to identify and verify the regulatory mechanism of DTNBP1 as a prognostic marker for hepatocellular carcinoma

Although the overall survival of hepatocellular carcinoma (HCC) patients has been significantly improved, prognostic clinical evaluation remains a substantial problem owing to the heterogeneity and complexity of tumor. A reliable and accurate predictive biomarker may assist physicians in better moni...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Xianyi, Li, Dezhi, Qi, Tiangyang, Sun, Jia, Zhou, Tao, Zheng, Wei V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742032/ https://www.ncbi.nlm.nih.gov/pubmed/34997064 http://dx.doi.org/10.1038/s41598-021-04055-4

Ejemplares similares

Genetic Effects of the Schizophrenia-Related Gene DTNBP1 in Temporal Lobe Epilepsy
por: Tao, Hua, et al.
Publicado: (2021)

S185. DTNBP1 IS ASSOCIATED WITH THE AGE AT ONSET OF KOREAN PATIENTS WITH SCHIZOPHRENIA
por: Lee, Kyuyoung, et al.
Publicado: (2018)

DTNBP1, a schizophrenia susceptibility gene, affects kinetics of transmitter release
por: Chen, Xiao-Wei, et al.
Publicado: (2008)

Combining Bioinformatics and Experiments to Identify and Verify Key Genes with Prognostic Values in Endometrial Carcinoma
por: Zhang, Wenchao, et al.
Publicado: (2020)

Glucosamine-6-Phosphate Isomerase 1 Promotes Tumor Progression and Indicates Poor Prognosis in Hepatocellular Carcinoma
por: Li, Dezhi, et al.
Publicado: (2020)

The effects of a DTNBP1 gene variant on attention networks: an fMRI study
por: Thimm, Markus, et al.
Publicado: (2010)

microRNA-378a-3p regulates the progression of hepatocellular carcinoma by regulating PD-L1 and STAT3
por: Li, Yaqin, et al.
Publicado: (2022)

A polymorphism in the dysbindin gene (DTNBP1) associated with multiple psychiatric disorders including schizophrenia
por: Voisey, Joanne, et al.
Publicado: (2010)

Association of DTNBP1 With Schizophrenia: Findings From Two Independent Samples of Han Chinese Population
por: Yang, Yongfeng, et al.
Publicado: (2020)

LINC02362 attenuates hepatocellular carcinoma progression through the miR-516b-5p/SOSC2 axis
por: Li, Dezhi, et al.
Publicado: (2022)

Deletion of Dtnbp1 in mice impairs threat memory consolidation and is associated with enhanced inhibitory drive in the amygdala
por: Huang, Cathy C. Y., et al.
Publicado: (2019)

Failure to confirm allelic and haplotypic association between markers at the chromosome 6p22.3 dystrobrevin-binding protein 1 (DTNBP1) locus and schizophrenia
por: Datta, Susmita R, et al.
Publicado: (2007)

RPNs Levels Are Prognostic and Diagnostic Markers for Hepatocellular Carcinoma
por: Zheng, Wangyang, et al.
Publicado: (2022)

Hermansky-Pudlak Syndrome: Identification of Novel Variants in the Genes HPS3, HPS5, and DTNBP1 (HPS-7)
por: Boeckelmann, Doris, et al.
Publicado: (2022)

Diagnostic and Prognostic Molecular Markers in Hepatocellular Carcinoma
por: Mínguez, Beatriz, et al.
Publicado: (2011)

Identification of CDCA2 as a Diagnostic and Prognostic Marker for Hepatocellular Carcinoma
por: Yu, Zhenjun, et al.
Publicado: (2021)

Prognostic alternative splicing regulatory network of RBM25 in hepatocellular carcinoma
por: Zhang, Yong-Fa, et al.
Publicado: (2021)

The DTNBP1 (dysbindin-1) gene variant rs2619522 is associated with variation of hippocampal and prefrontal grey matter volumes in humans
por: Trost, S., et al.
Publicado: (2012)

Regulatory T-cells-related signature for identifying a prognostic subtype of hepatocellular carcinoma with an exhausted tumor microenvironment
por: Zhang, Genhao
Publicado: (2022)

Integrated Proteomics and Bioinformatics to Identify Potential Prognostic Biomarkers in Hepatocellular Carcinoma
por: Zhang, Qifan, et al.
Publicado: (2021)

CtBP2 is an independent prognostic marker that promotes GLI1 induced epithelial-mesenchymal transition in hepatocellular carcinoma
por: Zheng, Xin, et al.
Publicado: (2015)

Association between the DTNBP1 gene and intelligence: a case-control study in young patients with schizophrenia and related disorders and unaffected siblings
por: Zinkstok, Janneke R, et al.
Publicado: (2007)

Cellular prognostic markers in hepatitis-related hepatocellular carcinoma
por: Petrizzo, A., et al.
Publicado: (2018)

KCNK levels are prognostic and diagnostic markers for hepatocellular carcinoma
por: Li, Wen-Chao, et al.
Publicado: (2019)

Prognostic value of inflammatory and nutritional markers for hepatocellular carcinoma
por: Xu, Yingying, et al.
Publicado: (2021)

Prognostic role of expression of angiogenesis markers in hepatocellular carcinoma: A bioinformatics analysis
por: Miao, Yan-Dong, et al.
Publicado: (2022)

Impaired long-term memory retention and working memory in sdy mutant mice with a deletion in Dtnbp1, a susceptibility gene for schizophrenia
por: Takao, Keizo, et al.
Publicado: (2008)

NLRC5, a valuable marker for the diagnosis and prognostic assessment of hepatocellular carcinoma
por: Zhang, Xiu-Wen, et al.
Publicado: (2020)

Peritumoral EpCAM Is an Independent Prognostic Marker after Curative Resection of HBV-Related Hepatocellular Carcinoma
por: Dai, Xiao-Meng, et al.
Publicado: (2017)

Verification of inflammation‐based prognostic marker as a prognostic indicator in hepatocellular carcinoma
por: Yamamoto, Masateru, et al.
Publicado: (2019)

From Bowen disease to cutaneous squamous cell carcinoma: eight markers were verified from transcriptomic and proteomic analyses
por: Biao, Tang, et al.
Publicado: (2022)

S100 Proteins as Diagnostic and Prognostic Markers in Colorectal and Hepatocellular Carcinoma
por: Maletzki, Claudia, et al.
Publicado: (2012)

Lrig1 is a positive prognostic marker in hepatocellular carcinoma
por: Yang, Bo, et al.
Publicado: (2016)

Prognostic ability of inflammation-based markers in radioembolization for hepatocellular carcinoma
por: Yoneoka, Grant, et al.
Publicado: (2020)

TMEM206 is a potential prognostic marker of hepatocellular carcinoma
por: Zhang, Li, et al.
Publicado: (2020)

Identification of miRNAs as diagnostic and prognostic markers in hepatocellular carcinoma
por: Liang, Hao, et al.
Publicado: (2021)

Identification of MCM4 as a Prognostic Marker of Hepatocellular Carcinoma
por: Zhou, Huandi, et al.
Publicado: (2021)

Identification of KNOP1 as a prognostic marker in hepatocellular carcinoma
por: Zhang, Yaping, et al.
Publicado: (2023)

Galad Score as a Prognostic Marker for Patients with Hepatocellular Carcinoma
por: Cagnin, Silvia, et al.
Publicado: (2023)

ABL1 Is a Prognostic Marker and Associated with Immune Infiltration in Hepatocellular Carcinoma
por: Liu, Rongqiang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8soope1khvc5c0094f9lptjv23